Based on the key indicators obtained from Pluri's historical financial statements, Pluri Inc is not in a good financial situation at this time. It has a very high odds of going through financial crisis in December. At this time, Pluri's Total Liabilities is relatively stable compared to the past year. As of 11/13/2024, Short and Long Term Debt Total is likely to grow to about 31.1 M, while Total Stockholder Equity is likely to drop slightly above 91.2 K. Key indicators impacting Pluri's financial strength include:
The essential information of the day-to-day investment outlook for Pluri includes many different criteria found on its balance sheet. An individual investor should monitor Pluri's cash flow, debt, and profitability to accurately make informed decisions on whether to invest in Pluri.
Net Income
(21.93 Million)
Pluri
Select Account or Indicator
Market Cap
Enterprise Value
Price To Sales Ratio
Ptb Ratio
Days Sales Outstanding
Book Value Per Share
Free Cash Flow Yield
Operating Cash Flow Per Share
Average Payables
Stock Based Compensation To Revenue
Capex To Depreciation
Pb Ratio
Ev To Sales
Free Cash Flow Per Share
Roic
Inventory Turnover
Net Income Per Share
Days Of Inventory On Hand
Payables Turnover
Sales General And Administrative To Revenue
Research And Ddevelopement To Revenue
Capex To Revenue
Cash Per Share
Pocfratio
Interest Coverage
Capex To Operating Cash Flow
Pfcf Ratio
Days Payables Outstanding
Income Quality
Roe
Ev To Operating Cash Flow
Pe Ratio
Return On Tangible Assets
Ev To Free Cash Flow
Earnings Yield
Net Debt To E B I T D A
Current Ratio
Tangible Book Value Per Share
Receivables Turnover
Graham Number
Shareholders Equity Per Share
Debt To Equity
Capex Per Share
Graham Net Net
Average Receivables
Revenue Per Share
Interest Debt Per Share
Debt To Assets
Enterprise Value Over E B I T D A
Short Term Coverage Ratios
Price Earnings Ratio
Operating Cycle
Price Book Value Ratio
Price Earnings To Growth Ratio
Days Of Payables Outstanding
Price To Operating Cash Flows Ratio
Price To Free Cash Flows Ratio
Pretax Profit Margin
Ebt Per Ebit
Operating Profit Margin
Effective Tax Rate
Company Equity Multiplier
Long Term Debt To Capitalization
Total Debt To Capitalization
Return On Capital Employed
Debt Equity Ratio
Ebit Per Revenue
Quick Ratio
Dividend Paid And Capex Coverage Ratio
Net Income Per E B T
Cash Ratio
Cash Conversion Cycle
Operating Cash Flow Sales Ratio
Days Of Inventory Outstanding
Days Of Sales Outstanding
Free Cash Flow Operating Cash Flow Ratio
Cash Flow Coverage Ratios
Price To Book Ratio
Fixed Asset Turnover
Capital Expenditure Coverage Ratio
Price Cash Flow Ratio
Enterprise Value Multiple
Debt Ratio
Cash Flow To Debt Ratio
Price Sales Ratio
Return On Assets
Asset Turnover
Net Profit Margin
Gross Profit Margin
Price Fair Value
Return On Equity
Change In Cash
Free Cash Flow
Change In Working Capital
Begin Period Cash Flow
Other Cashflows From Financing Activities
Capital Expenditures
Total Cash From Operating Activities
Net Income
Total Cash From Financing Activities
End Period Cash Flow
Change To Inventory
Depreciation
Other Non Cash Items
Change To Account Receivables
Stock Based Compensation
Investments
Total Cashflows From Investing Activities
Change To Operating Activities
Other Cashflows From Investing Activities
Change To Netincome
Change To Liabilities
Issuance Of Capital Stock
Total Assets
Other Current Liab
Total Current Liabilities
Total Stockholder Equity
Net Debt
Retained Earnings
Accounts Payable
Cash
Non Current Assets Total
Non Currrent Assets Other
Cash And Short Term Investments
Common Stock Shares Outstanding
Liabilities And Stockholders Equity
Other Stockholder Equity
Total Liab
Total Current Assets
Common Stock
Short Long Term Debt Total
Property Plant And Equipment Net
Current Deferred Revenue
Net Receivables
Non Current Liabilities Total
Accumulated Other Comprehensive Income
Short Term Debt
Other Current Assets
Short Term Investments
Inventory
Other Liab
Net Tangible Assets
Other Assets
Property Plant Equipment
Net Invested Capital
Net Working Capital
Capital Lease Obligations
Property Plant And Equipment Gross
Long Term Debt
Interest Expense
Gross Profit
Other Operating Expenses
Operating Income
Ebit
Ebitda
Cost Of Revenue
Total Operating Expenses
Income Tax Expense
Depreciation And Amortization
Selling General Administrative
Research Development
Income Before Tax
Total Other Income Expense Net
Total Revenue
Net Income Applicable To Common Shares
Net Interest Income
Interest Income
Net Income From Continuing Ops
Reconciled Depreciation
Minority Interest
Probability Of Bankruptcy
Understanding current and past Pluri Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Pluri's financial statements are interrelated, with each one affecting the others. For example, an increase in Pluri's assets may result in an increase in income on the income statement.
Pluri competes with Cullinan Oncology, Aerovate Therapeutics, Structure Therapeutics, Lyra Therapeutics, and Gossamer Bio. Pluri Inc., a biotechnology company, focuses on the development of placenta-based cell therapy product candidates for the treatment of inflammatory, muscle injuries, and hematologic conditions. Pluri Inc. was incorporated in 2001 and is based in Haifa, Israel. Pluri operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 154 people.
Specialization
Health Care, Pharmaceuticals, Biotechnology & Life Sciences
The reason investors look at the income statement is to determine what Pluri's earnings per share (EPS) will be in order to see if they want to buy more shares or not. For example, if a company earned $20 million in the last quarter and has 100,000 shares outstanding, its EPS is 20 cents. If you find that this number beats analysts' forecasts or is higher than it was from the same period last year, then you might want to buy more of this stock even though its price per share may not have changed.
Comparative valuation techniques use various fundamental indicators to help in determining Pluri's current stock value. Our valuation model uses many indicators to compare Pluri value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Pluri competition to find correlations between indicators driving Pluri's intrinsic value. More Info.
Pluri Inc is rated below average in return on equity category among its peers. It is regarded fourth in return on asset category among its peers . At this time, Pluri's Return On Equity is relatively stable compared to the past year. Comparative valuation analysis is a catch-all technique that is used if you cannot value Pluri by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.
Pluri Inc Systematic Risk
Pluri's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Pluri volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was twenty-four with a total number of output elements of thirty-seven. The Beta measures systematic risk based on how returns on Pluri Inc correlated with the market. If Beta is less than 0 Pluri generally moves in the opposite direction as compared to the market. If Pluri Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Pluri Inc is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Pluri is generally in the same direction as the market. If Beta > 1 Pluri moves generally in the same direction as, but more than the movement of the benchmark.
Today, most investors in Pluri Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Pluri's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Pluri growth as a starting point in their analysis.
Along with financial statement analysis, the daily predictive indicators of Pluri help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Pluri Inc. We use our internally-developed statistical techniques to arrive at the intrinsic value of Pluri Inc based on widely used predictive technical indicators. In general, we focus on analyzing Pluri Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Pluri's daily price indicators and compare them against related drivers.
When running Pluri's price analysis, check to measure Pluri's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pluri is operating at the current time. Most of Pluri's value examination focuses on studying past and present price action to predict the probability of Pluri's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pluri's price. Additionally, you may evaluate how the addition of Pluri to your portfolios can decrease your overall portfolio volatility.